United States · FDA National Drug Code directory
QUETIAPINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43547-020_058aac79-3e9f-46b2-a2f8-693ffb211aef
- Product NDC
- 43547-020
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- quetiapine
- Labeler
- Solco Healthcare U.S., LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220401
- Source listing expiry
- 20261231
Source-listed ingredients
- QUETIAPINE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-020-06) · 43547-020-06
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-020-50) · 43547-020-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →